Jie Wen

1.3k citations
37 papers · 843 indexed · h-index 17
Topics
Cancer-related molecular mechanisms research (6 papers)Pain Mechanisms and Treatments (4 papers)Liver Disease Diagnosis and Treatment (4 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS GeneticsGene
Partner nations
ChinaSwedenIreland

In The Last Decade

Jie Wen

37 papers receiving 825 citations

Peers

Jie Wen
Comparison fields: 5 of 89
  • Molecular Biology 245
  • Epidemiology 236
  • Endocrinology, Diabetes and Metabolism 233
  • Physiology 154
  • Nephrology 147
Replace Lianxi Li with:
Lianxi Li China
Min He China
John Cardinal Australia
Guangda Xiang China
Satoshi Minami Japan
Yacheng Pan China
Hideaki Nakatsuji Japan
Karina Thieme Brazil
Olivia Lenoir France
Daniel Cuevas‐Ramos Mexico
Jie Wen relative to Lianxi Li China Lianxi Li's profile →
Citations per field
00.5×1.5×
Lianxi Li · 1×
Citations per year

Countries citing papers authored by Jie Wen

Since Specialization
Citations

This map shows the geographic impact of Jie Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Wen more than expected).

Fields of papers citing papers by Jie Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Wen. The network helps show where Jie Wen may publish in the future.

Co-authorship network of co-authors of Jie Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Wen. A scholar is included among the top collaborators of Jie Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Wen. Jie Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 1
4 7
5 9
6 22
7
Inhibition of human glioblastoma cell invasion involves PION@E6 mediated autophagy process
1
8 20
9 23
10 16
11 15
12 12
13 26
14 15
15 69
16 16
17 107
18 32
19 15
20 54

About Jie Wen

Jie Wen is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Clinical Biochemistry, having authored 37 papers that have together received 843 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Pain Mechanisms and Treatments (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Nephrology (147 citations), Endocrinology, Diabetes and Metabolism (233 citations) and Cancer Research (124 citations). Jie Wen has collaborated with scholars based in China, Sweden and Ireland. Frequent co-authors include Bin Lü, Renming Hu, Zhaoyun Zhang, Xiaoming Tao, Xuanchun Wang, Weiwei Zhang, Min He, Ying Huang, Lili Chen and Shen Qu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS Genetics and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026